Form S-3 CytoDyn Inc.
http://archive.fast-edgar.com/20260925/A8LHB22CZ22CK242222M22Z2G8M2ZZ223282
Filed on: September 25, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aclaris Therapeutics prices $50M common stock offering
- Meta prices $25B common stock and $12.5B preferred share offerings
- Equillium doses first subject in EQ504 Phase 1 trial, raises $20M
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S3Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share